Femring (Allergan, Inc.)
Welcome to the PulseAid listing for the Femring drug offered from Allergan, Inc.. This Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan, Inc. |
NON-PROPRIETARY NAME: | estradiol acetate |
SUBSTANCE NAME: | ESTRADIOL ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
ROUTE: | VAGINAL |
DOSAGE FORM: | RING |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-05-02 |
END MARKETING DATE: | 0000-00-00 |
Femring HUMAN PRESCRIPTION DRUG Details:
Item Description | Femring from Allergan, Inc. |
LABELER NAME: | Allergan, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.05(mg/d) |
START MARKETING DATE: | 2016-05-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0023-5868_3daf6e91-1830-49c7-b50e-1a7e856d968a |
PRODUCT NDC: | 0023-5868 |
APPLICATION NUMBER: | NDA021367 |
Other ESTRADIOL ACETATE Pharmaceutical Manufacturers / Labelers: